{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-047322","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2024-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.423021+00:00","generated_at":"2026-06-03T22:56:14.848165+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Outlook Therapeutics closes $5M private placement to Syntone Ventures","bullets":["Issued 714,286 shares and warrants to purchase 1,071,429 shares at $7.00 per share+ warrant.","Warrant exercise price is $7.70 per share, expiring April 15, 2029.","Sale relied on Section 4(a)(2) and Rule 506 exemptions without registration.","Syntone Ventures LLC is the sole investor in the private placement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-047322","json":"https://secwatch.observer/filing/0001104659-24-047322.json","markdown":"https://secwatch.observer/filing/0001104659-24-047322.md","text":"https://secwatch.observer/filing/0001104659-24-047322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/0001104659-24-047322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/tm2411870d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:56:14.848165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}